What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Breast cancer
Her main research concerns Breast cancer, Internal medicine, Oncology, Cancer and Gynecology.
Her Breast cancer research incorporates elements of Prospective cohort study and Genome-wide association study, Single-nucleotide polymorphism.
Caroline Seynaeve focuses mostly in the field of Internal medicine, narrowing it down to matters related to Surgery and, in some cases, Mastectomy, Prophylactic Mastectomy and Bilateral Prophylactic Mastectomy.
She has included themes like Cohort study, CHEK2, Cyclophosphamide, Hazard ratio and Survival analysis in her Oncology study.
Her studies deal with areas such as Histopathology, Germline mutation and Cancer research as well as Cancer.
Her work deals with themes such as Mammography, Confidence interval, Tamoxifen, Physical examination and Risk factor, which intersect with Gynecology.
Her most cited work include:
- Breast Cancer After Prophylactic Bilateral Mastectomy in Women With a BRCA1 or BRCA2 Mutation (828 citations)
- MicroRNA related polymorphisms and breast cancer risk (582 citations)
- Association analysis identifies 65 new breast cancer risk loci (569 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Oncology, Cancer and Gynecology.
Her Breast cancer research focuses on Estrogen receptor in particular.
Her Oncology study integrates concerns from other disciplines, such as Odds ratio, Surgery, Case-control study, Mastectomy and Cohort.
Caroline Seynaeve has researched Cancer in several fields, including Germline mutation and Disease, Incidence, Pathology.
Her Gynecology research is multidisciplinary, incorporating elements of Prophylactic Mastectomy, Mammography, Distress, Obstetrics and Risk factor.
Her Genome-wide association study research incorporates themes from Genetic association and Genetic predisposition.
She most often published in these fields:
- Breast cancer (72.64%)
- Internal medicine (67.91%)
- Oncology (57.71%)
What were the highlights of her more recent work (between 2014-2021)?
- Breast cancer (72.64%)
- Internal medicine (67.91%)
- Oncology (57.71%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Breast cancer, Internal medicine, Oncology, Tamoxifen and Hazard ratio.
Breast cancer is a subfield of Cancer that she tackles.
Caroline Seynaeve usually deals with Internal medicine and limits it to topics linked to Gynecology and Young adult and Prospective cohort study.
The concepts of her Oncology study are interwoven with issues in Odds ratio, Metastatic breast cancer, Ovarian cancer, Estrogen receptor and Adjuvant therapy.
Her Tamoxifen research incorporates elements of Randomized controlled trial and Early breast cancer.
Her research in Hazard ratio intersects with topics in Discontinuation, Cumulative incidence and Predictive marker.
Between 2014 and 2021, her most popular works were:
- Association analysis identifies 65 new breast cancer risk loci (569 citations)
- RAD51B in Familial Breast Cancer (399 citations)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Breast cancer
Caroline Seynaeve focuses on Breast cancer, Internal medicine, Oncology, Genome-wide association study and Hazard ratio.
Her Breast cancer research is under the purview of Cancer.
Her Cancer research includes elements of Stroke, Magnetic resonance imaging, Radiology and Subclinical infection.
Her Oncology research is multidisciplinary, incorporating perspectives in Odds ratio, Circulating tumor cell, Metastatic breast cancer, Estrogen receptor and Cohort.
Her Genome-wide association study research integrates issues from Genetic association and Genetic predisposition.
The study incorporates disciplines such as Aromatase inhibitor and Anastrozole in addition to Gynecology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
